Reliability and validity of the Functional Assessment of Cancer Therapy General (FACT-G) in French cancer patients

Quality of Life Research

Volumn 14, Issue 5, 2005, Pages 1427-1432

  Costet, Nathalie ^a,b   Lapierre, Valérie ^c   Benhamou, Ellen ^c   Le Galès, Catherine ^a  

^a INSERM   (France)

^b ENSAI Ecole Nationale de la Statistique et de lAnalyse de lInformation   (France)

^c INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Cancer; Cross cultural adaptation; France; Functional Assessment of Cancer Therapy (FACT)

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; CANCER; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER REGRESSION; CONTROLLED STUDY; FAMILY; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; OUTCOMES RESEARCH; PRIORITY JOURNAL; RELIABILITY; SOCIAL ASPECT; WELLBEING;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; FRANCE; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS; PSYCHOMETRICS; QUALITY OF LIFE; QUESTIONNAIRES; RADIATION ONCOLOGY; SICKNESS IMPACT PROFILE; TRANSLATING;

EID: 21244445053     PISSN: 09629343     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11136-004-5531-z     Document Type: Article

References (25)

1. H Schipper J Clinch A McMurray M Levitt 1984 Measuring the quality of life of cancer patients: the Functional Living Index.Cancer: Development and validation J Clin Oncol 5 472 483
2. NK Aaronson S Ahmedzai B Bergman 1993 for the European Organisation for Research and Treatment of Cancer QLQ C30 for the European Organisation for Research and Treatment of Cancer Study group on Quality of Life. The EORTC QLQ-C30: A quality of life instrument for use in international clinical trials in oncology J Nat Cancer Inst 85 365 376
3. DF Cella DS Tulsky G Gray 1993 The Functional Assessment of Cancer Therapy Scale: Development and validation of the general measure J Clin Oncol 11 3 570 579
4. Fayers PM, Machin D. Quality of life - Assessment, Analysis and Interpretation. Wiley,2000.
5. Cramer JA, Spilker B. Quality of Life and Pharmacoeconomics. Lippincott-Raven, 1998.
6. DF Cella AE Bonomi SR Lloyd DS Tulsky E Kaplan P Bonomi 1995 Reliability and validity of the Functional Assessment of Cancer Therapy - Lung (FACT-L) quality of life instrument Lung Cancer 12 199 220
7. MJ Brady DF Cella F Mo 1997 Reliability and validity of the Functional Assessment of Cancer Therapy-Breast (FACT-B) quality of life instrument Journal of Clinical Oncology 15 974 986
8. P Esper F Mo G Chodak M Sinner DF Cella KJ Pienta 1997 Measuring quality of life in men with prostate cancer using the Functional Assessment of Cancer Therapy - Prostate (FACT-P) instrument Urology 50 6 920 928
9. DF Cella NL McCain AH Peterman F Mo D Wolen 1996 Development and validation of the Functional Assessment of Human Immunodeficiency Virus Infection (FAHI) quality of life instrument Qual Life Res 5 450 463
10. DF Cella K Dineen B Arnason 1996 Validation of the Functional Assessment of Multiple Sclerosis quality of life instrument Neurology 47 129 139
11. AE Bonomi DF Cella EA Hahn 1996 Multilingual translation of Functional Assessement of Cancer Therapy (FACT) quality of life measurement system Qual Life Res 5 309 320
12. http://www.facit.org/.
13. S.M Hunt J Alonso D Bucquet M Niero I Wiklund S McKenna 1991 Cross-cultural adaptation of health measures Health Policy 19 33 44 European group for Health Measurement and Quality of Life Assessment
14. M Herdman J Fox-Rushby X Badia 1997 Equivalence and the translation of health-related quality of life questionnaires Qual Life Res 6 237 247
15. JE Ware SD Keller B Gandek JE Brazier M Sullivan 1995 Evaluating translations of health status questionnaires Int J Technol Assessment Health Care 11 3 525 551 the IQOLA Project Group
16. PR Reese A Joseph 1995 Quality translations - no substitution for psychometric evaluation Qual Life Res 4 573 574 (abstract)
17. LJ Cronbach 1951 Coefficient alpha and the internal structure of tests Psychometrika 16 297 334
18. RA Deyo P Diehr DL Patrick 1991 Reproducibility and responsiveness oh health status measures: statistics and strategies for evaluation Controlled Clinical Trials 12 142S 158S
19. J Cohen 1988 Statistical Power Analysis for the Behavioral Sciences 2 Lawrence Erlbaum Hillsdale, NJ
20. MA Weitzner CA Meyers CK Gelke KS Byrne DF Cella VA Levin 1995 The Functional Assessment of Cancer Therapy Scale.Development of a brain subscale and revalidation of the general version (FACT-G) in patients with primary brain tumors Cancer 75 5 1151 1161
21. P Winstead-Fry A Schultz 1997 Psychometric analysis of the Functional Assessment of Cancer Therapy-General (FACT-G) scale in a rural sample Cancer 79 12 2446 2452
22. D Osoba 1994 Lessons learned from measuring health-related quality of life in oncology J Clin Oncol 12 3 608 616
23. Fairclough DL. Design and Analysis of Quality of Life Studies in Clinical Trials. Chapman and Hall/CRC, 2002.
24. R Jaeschke J Singer GH Guyatt 1989 Measurement of health status: Ascertaining the minimal clinically important difference Control Clin Trials 10 407 415
25. EF Juniper GH Guyatt A Willan LE Griffith 1994 Determining a minimal important change in a disease-specific quality of life questionnaire J Clin Epidemiol 47 81 87